| CYTOSORBENTS CORP. DL-,01 |
| USA |
| Gesundheit |
| US23283X2062 / A12GDU |
| HQE1 (Frankfurt) / CTSO (NASDAQ) |
| FRA:HQE1, ETR:HQE1, HQE1:GR, NASDAQ:CTSO |
| - |
| http://www.cytosorbents.c.. |
|
CytoSorbents Corporation is a medical device company focused on blood purification technologies for critical care and cardiac surgery. CytoSorbents Corporation develops and commercializes products that use hemoadsorption to remove harmful substances ..
>Volltext.. |
| 18.33 Mio. EUR |
| 40.73 Mio. EUR |
| 32.12 Mio. EUR |
| -8.82 Mio. EUR |
| -15.72 Mio. EUR |
| -0.25 EUR |
| 25.88 Mio. EUR |
| 3.81 Mio. EUR |
| -7.89 Mio. EUR |
| 0.18 |
| 12.05% |
| -92.69% |
| - |
| - |
| - |
| - |
| CYTOSORBENTS |
| 04.09.26 |
|
||||
|
||||
|
||||
|
||||
|
||||
|